Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Depreciation & Amortization

$739.00K

TTM · Period ending: · USD

LCTX logo

LCTX Depreciation & Amortization

Latest reported$739.00K
LCTX TTM Depreciation & Amortization ($0.00 → $739.00K)
High-resolution chart · PNG

LCTX depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
74,704
76,653
75,458
56,130
36,783
18,254
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.